OBJECTIVES: To report on survival from a large multicenter cohort of neonates with hypoplastic left heart syndrome requiring extracorporeal membrane oxygenation-assisted cardiopulmonary resuscitation after stage 1 palliation operation. DESIGN: Retrospective analysis of data from the Extracorporeal Life Support Organization data registry (1998 through 2013). We computed the survival to hospital discharge for neonates (age < 30 d) who required extracorporeal membrane oxygenation after stage 1 palliation and evaluated factors associated with mortality using multivariate logistic regression analysis. SETTING: Multicenter data reported to Extracorporeal Life Support Organization registry. PATIENTS: Infants with hypoplastic left heart syndrome after stage 1 palliation who received extracorporeal membrane oxygenation-assisted cardiopulmonary resuscitation. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: There were 307 extracorporeal membrane oxygenation runs in the setting of extracorporeal membrane oxygenation-assisted cardiopulmonary resuscitation in 293 neonates with hypoplastic left heart syndrome following stage 1 palliation operation. The median age at cannulation was 9 days (interquartile range, 5-14 d). Survival to hospital discharge was 36%. In univariate analysis, gestational age, weight, extracorporeal membrane oxygenation duration, presence of air embolism, hemorrhagic complications, renal failure, and pulmonary complications (pulmonary hemorrhage and pneumothorax) were all associated with nonsurvival. In multivariate analysis, lower body weight at cannulation (odds ratio, 3.9; 95% CI, 1.9-8.3), duration of the extracorporeal membrane oxygenation (odds ratio, 3.4; 95% CI, 1.9-7.3), and renal failure while on extracorporeal membrane oxygenation (odds ratio, 2; 95% CI, 1.2-3.5) increased odds of mortality. CONCLUSIONS: Mortality for neonates with hypoplastic left heart syndrome supported with extracorporeal membrane oxygenation-assisted cardiopulmonary resuscitation after stage 1 palliation is high. Lower body weight, increased duration of extracorporeal membrane oxygenation support, and renal failure increased mortality.
OBJECTIVES: To report on survival from a large multicenter cohort of neonates with hypoplastic left heart syndrome requiring extracorporeal membrane oxygenation-assisted cardiopulmonary resuscitation after stage 1 palliation operation. DESIGN: Retrospective analysis of data from the Extracorporeal Life Support Organization data registry (1998 through 2013). We computed the survival to hospital discharge for neonates (age < 30 d) who required extracorporeal membrane oxygenation after stage 1 palliation and evaluated factors associated with mortality using multivariate logistic regression analysis. SETTING: Multicenter data reported to Extracorporeal Life Support Organization registry. PATIENTS: Infants with hypoplastic left heart syndrome after stage 1 palliation who received extracorporeal membrane oxygenation-assisted cardiopulmonary resuscitation. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: There were 307 extracorporeal membrane oxygenation runs in the setting of extracorporeal membrane oxygenation-assisted cardiopulmonary resuscitation in 293 neonates with hypoplastic left heart syndrome following stage 1 palliation operation. The median age at cannulation was 9 days (interquartile range, 5-14 d). Survival to hospital discharge was 36%. In univariate analysis, gestational age, weight, extracorporeal membrane oxygenation duration, presence of air embolism, hemorrhagic complications, renal failure, and pulmonary complications (pulmonary hemorrhage and pneumothorax) were all associated with nonsurvival. In multivariate analysis, lower body weight at cannulation (odds ratio, 3.9; 95% CI, 1.9-8.3), duration of the extracorporeal membrane oxygenation (odds ratio, 3.4; 95% CI, 1.9-7.3), and renal failure while on extracorporeal membrane oxygenation (odds ratio, 2; 95% CI, 1.2-3.5) increased odds of mortality. CONCLUSIONS: Mortality for neonates with hypoplastic left heart syndrome supported with extracorporeal membrane oxygenation-assisted cardiopulmonary resuscitation after stage 1 palliation is high. Lower body weight, increased duration of extracorporeal membrane oxygenation support, and renal failure increased mortality.
Authors: Javier J Lasa; Parag Jain; Tia T Raymond; Charles G Minard; Alexis Topjian; Vinay Nadkarni; Michael Gaies; Melania Bembea; Paul A Checchia; Lara S Shekerdemian; Ravi Thiagarajan Journal: Pediatr Crit Care Med Date: 2018-02 Impact factor: 3.624
Authors: Richard P Fernandez; Brian F Joy; Robin Allen; Jamie Stewart; Holly Miller-Tate; Yongjie Miao; Lisa Nicholson; Clifford L Cua Journal: Pediatr Cardiol Date: 2016-11-01 Impact factor: 1.655
Authors: Javier J Lasa; Rachel S Rogers; Russell Localio; Justine Shults; Tia Raymond; Michael Gaies; Ravi Thiagarajan; Peter C Laussen; Todd Kilbaugh; Robert A Berg; Vinay Nadkarni; Alexis Topjian Journal: Circulation Date: 2015-12-03 Impact factor: 29.690
Authors: Marissa A Brunetti; J William Gaynor; Lauren B Retzloff; Jessica L Lehrich; Mousumi Banerjee; Venugopal Amula; David Bailly; Darren Klugman; Josh Koch; Javier Lasa; Sara K Pasquali; Michael Gaies Journal: Pediatr Crit Care Med Date: 2018-06 Impact factor: 3.624
Authors: Kathleen L Meert; Ralph Delius; Beth S Slomine; James R Christensen; Kent Page; Richard Holubkov; J Michael Dean; Frank W Moler Journal: Ann Thorac Surg Date: 2018-12-14 Impact factor: 4.330
Authors: Kathleen L Meert; Anne-Marie Guerguerian; Ryan Barbaro; Beth S Slomine; James R Christensen; John Berger; Alexis Topjian; Melania Bembea; Sarah Tabbutt; Ericka L Fink; Steven M Schwartz; Vinay M Nadkarni; Russell Telford; J Michael Dean; Frank W Moler Journal: Crit Care Med Date: 2019-03 Impact factor: 7.598
Authors: Rodrigo Freire Bezerra; Juliana Torres Pacheco; Victor Hugo Volpatto; Sônia Meiken Franchi; Rosangela Fitaroni; Denilson Vieira da Cruz; Rodrigo Moreira Castro; Luciana da Fonseca da Silva; José Pedro da Silva Journal: Front Pediatr Date: 2022-03-02 Impact factor: 3.418